Exoprise Recognized by CRN as a 2014 Emerging Vendor

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Exoprise Recognized by CRN as a 2014 Emerging Vendor

WALTHAM, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Exoprise , a provider of application performance management and monitoring solutions for business cloud applications and services, announced today that it has been recognized as one of 2014's hottest emerging technology vendors by CRN , the top news source for solution providers and the IT channel. The annual Emerging Vendors list identifies up-and-coming technology vendors that have introduced innovative new products, creating opportunities for channel partners in North America to create high-margin, cutting-edge solutions for their customers.

Exoprise CloudReady® is the only application performance monitoring solution that provides real-time performance and availability insight into the leading mission-critical cloud offerings including Microsoft Office 365 and Azure, Amazon Web Services, Google Apps and Salesforce.com. It enables users to analyze measurements from their service locations against global and regional crowd data, helping to quickly identify and fix performance-impacting issues regardless of where they happen.

Unlike on-premise deployments, where IT teams can monitor performance via direct access to the servers running their applications, visibility to cloud-based apps and websites is typically limited to basic service dashboards. While these dashboards can provide current status of a particular app or service, they do not provide real-time end-to-end performance data, nor can they provide information on the health and availability of the various networks - the customer's, the ISP's, the Internet backbone, etc. connecting the users to the service.

Exoprise CloudReady helps Systems Integrators and Managed Service Providers grow their business by moving their customers to the cloud faster and with more confidence. The solutions set customers at ease regarding cloud and SaaS application performance and availability, enabling solution providers to pursue and close more cloud opportunities and deliver more value-added services.

"Solution providers are always on the hunt for the next big technology trend so that they can bring new solutions to their customers before they even know they need them. These vendors are on the forefront of IT innovation and are offering products and services that channel partners can use to stay ahead of the competition," said Robert Faletra, CEO of The Channel Company, publisher of CRN. "We congratulate 2014's Emerging Vendors for creating the next wave of technology that will drive the IT industry forward and for opening the door to new, unique solutions from the IT channel."

"The recent cloud service outages underscore the critical need for monitoring solutions that are purpose-built for the cloud," said Mark Yohai, vice president of sales and business development. "Traditional application performance monitoring tools are not up to the challenges of cloud applications and solution providers need tools to support their customers' mission critical cloud applications. We're pleased to be recognized by CRN."

Companies included in CRN's 2014 Emerging Vendors list were founded in 2008 or later and are actively working with channel partners in North America. The list, along with information about each vendor, will be published in CRN's August 2014 issue and will also be available online at www.crn.com .

About Exoprise

Exoprise empowers IT teams with solutions that enable effective adoption and management of mission-critical, cloud based applications and services with its CloudReady application performance management solution. CloudReady provides real-time performance visibility from behind the firewall to the cloud and back. This synthetic monitoring technology also leverages network path diagnostics and crowd sourced data analytics to pinpoint problems and ensure the best possible cloud service performance. Exoprise helps customers get to the cloud faster and ensure success once they are there. Visit Exoprise at www.exoprise.com ; on Twitter @exoprise ; and on LinkedIn .

About The Channel Company

The Channel Company is the channel community's trusted authority for growth and innovation, with established brands including CRN, XChange Events, IPED, and SharedVue. For more than three decades, we have leveraged our proven and leading-edge platforms to deliver prescriptive sales and marketing solutions for the technology channel. The Channel Company provides Communication, Recruitment, Engagement, Enablement, Demand Generation and Intelligence services to drive technology partnerships. Learn more at www.thechannelcompany.com .

For Exoprise Tim Walsh Walsh Group Marketing 617.512.1641 For CRN Betzi Hanc The Channel Company 508.416.1182

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading